Piqray (Alpelisib) for Breast Cancer

Overview

Piqray is a prescription medication approved by the Food and Drug Administration (FDA) to treat advanced or metastatic breast cancer in postmenopausal women. Piqray is also known by its drug name, Alpelisib.

Piqray is a kinase inhibitor. Piqray is believed to work by inhibiting kinases, proteins involved in cell signaling for tumor growth.

How do I take it?

Piqray is taken orally once a day.

Piqray is available in tablet form.

Side effects

The FDA-approved label for Piqray lists common side effects including changes in blood sugar levels, diarrhea, rash, decreased white blood cell count, nausea, fatigue, decreased appetite, inflammation of the mouth and lips, vomiting, weight loss, low calcium levels, abnormal bleeding, and hair loss.

Rare but serious side effects listed for Piqray can include severe hypersensitivity, severe skin reactions, hyperglycemia, inflammation of the lungs, and severe diarrhea.

For more information, visit:
Piqray - Novartis
https://www.us.piqray.com/